Regeneron Pharmaceuticals, Inc. SEC filings REGN
Regeneron Pharmaceuticals, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Aug 29, 2017. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Oct 30, 2026 | Oct 30, 2026 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Oct 6, 2026 | Oct 1, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 30, 2026 | Sep 24, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2026 | Jul 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 6, 2026 | Jul 6, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2026 | Jun 12, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 29, 2026 | Apr 29, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 8, 2026 | Apr 8, 2026 |
| 8-K |
Current report
Results of operations
|
Jan 30, 2026 | Jan 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 28, 2025 | Oct 28, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 6, 2025 | Oct 6, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2025 | Aug 1, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2025 | Jun 13, 2025 |
| 8-K |
Current report
Results of operations
|
Apr 29, 2025 | Apr 29, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
Feb 4, 2025 | Feb 4, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 31, 2024 | Oct 31, 2024 |
| 8-K |
Current report
Results of operations
|
Oct 7, 2024 | Oct 7, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2024 | Aug 1, 2024 |
| 8-K |
Current report
Results of operations
|
Jul 8, 2024 | Jul 8, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Results of operations
|
May 2, 2024 | May 2, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 2, 2024 | Feb 2, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 31, 2024 | Jan 26, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Results of operations
|
Oct 5, 2023 | Oct 5, 2023 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Sep 8, 2023 | Jun 9, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 8, 2023 | Sep 1, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 14, 2023 | Jun 9, 2023 |
| 8-K |
Current report
Results of operations
|
May 4, 2023 | May 4, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 17, 2023 | Apr 14, 2023 |
| 8-K |
Current report
Results of operations
|
Apr 10, 2023 | Apr 10, 2023 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 29, 2023 | Mar 27, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 3, 2023 | Feb 3, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 9, 2023 | Jan 9, 2023 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
Dec 20, 2022 | Dec 19, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2022 | Nov 3, 2022 |
| 8-K |
Current report
Officer or director change
|
Oct 3, 2022 | Oct 3, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2022 | Aug 3, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2022 | Jun 10, 2022 |
| 8-K |
Current report
Material agreement
|
Jun 2, 2022 | Jun 1, 2022 |
| 8-K |
Current report
Results of operations
|
May 4, 2022 | May 4, 2022 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 8, 2022 | Mar 2, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 4, 2022 | Feb 4, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2021 | Nov 4, 2021 |
| 8-K |
Current report
Material agreement
|
Sep 16, 2021 | Sep 14, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2021 | Aug 5, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2021 | Jun 11, 2021 |
| 8-K |
Current report
Results of operations
|
May 6, 2021 | May 6, 2021 |
| 8-K |
Current report
Results of operations
|
Feb 5, 2021 | Feb 5, 2021 |
| 8-K |
Current report
Material agreement
|
Jan 15, 2021 | Jan 12, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 11, 2021 | Jan 11, 2021 |
| 8-K |
Current report
Officer or director change
|
Jan 5, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| 8-K |
Current report
Material agreement
|
Aug 19, 2020 | Aug 18, 2020 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Aug 12, 2020 | Aug 7, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2020 | Aug 5, 2020 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 7, 2020 | Jul 6, 2020 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 16, 2020 | Jun 12, 2020 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 29, 2020 | May 25, 2020 |
| 8-K |
Current report
Results of operations
|
May 5, 2020 | May 5, 2020 |
| 8-K |
Current report
Material agreement
|
Apr 7, 2020 | Apr 5, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 6, 2020 | Feb 6, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2020 | Jan 13, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2019 | Nov 5, 2019 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2019 | Aug 6, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 19, 2019 | Jun 14, 2019 |
| 8-K/A |
Amended current report
Regulation FD disclosure
|
May 7, 2019 | May 7, 2019 |
| 8-K |
Current report
Results of operations
|
May 7, 2019 | May 7, 2019 |
| 8-K |
Current report
Material agreement, New debt
|
May 3, 2019 | May 2, 2019 |
| 8-K |
Current report
Material agreement
|
Apr 10, 2019 | Apr 8, 2019 |
| 8-K |
Current report
Results of operations
|
Feb 6, 2019 | Feb 6, 2019 |
| 8-K |
Current report
Material agreement, Results of operations, Regulation FD disclosure
|
Jan 7, 2019 | Jan 2, 2019 |
| 8-K |
Current report
Material agreement, Agreement ended, New debt
|
Dec 17, 2018 | Dec 14, 2018 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2018 | Nov 6, 2018 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 12, 2018 | Oct 10, 2018 |
| 8-K |
Current report
Results of operations
|
Aug 2, 2018 | Aug 2, 2018 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2018 | Jun 8, 2018 |
| 8-K |
Current report
Results of operations
|
May 3, 2018 | May 3, 2018 |
| 8-K |
Current report
Results of operations
|
Feb 8, 2018 | Feb 8, 2018 |
| 8-K |
Current report
Officer or director change
|
Jan 18, 2018 | Jan 15, 2018 |
| 8-K |
Current report
Material agreement, Results of operations, Regulation FD disclosure
|
Jan 8, 2018 | Jan 7, 2018 |
| 8-K |
Current report
Officer or director change
|
Jan 2, 2018 | Jan 2, 2018 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2017 | Nov 8, 2017 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Sep 13, 2017 | Sep 13, 2017 |
Showing 89 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- REGN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NY
- Headquarters
- Tarrytown, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 872589
- Former names
- REGENERON PHARMACEUTICALS INC (until Jun 19, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.